Valentina Boasi

ORCID: 0000-0003-0156-4273
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Acute Myocardial Infarction Research
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Coronary Interventions and Diagnostics
  • Acute Kidney Injury Research
  • Cardiac Valve Diseases and Treatments
  • Infective Endocarditis Diagnosis and Management
  • Erythropoietin and Anemia Treatment
  • Photoacoustic and Ultrasonic Imaging
  • Pericarditis and Cardiac Tamponade
  • Cardiac Imaging and Diagnostics
  • Health Systems, Economic Evaluations, Quality of Life
  • Cardiac and Coronary Surgery Techniques
  • Computational Drug Discovery Methods
  • Neutrophil, Myeloperoxidase and Oxidative Mechanisms
  • Inflammasome and immune disorders
  • Renal and Vascular Pathologies
  • Cardiac pacing and defibrillation studies
  • COVID-19 Clinical Research Studies
  • Atrial Fibrillation Management and Outcomes
  • Ocular and Laser Science Research
  • Sepsis Diagnosis and Treatment
  • Heart Failure Treatment and Management
  • Diabetes Treatment and Management

Ospedale di Sanremo
2017-2022

University of Genoa
2009

European guidelines recommend the use of ticagrelor versus clopidogrel in patients with ST elevation myocardial infarction (STEMI). This recommendation is based on inconclusive results and subanalyses from clinical trials. Few data are available effects a real-world population. To compare STEMI population, we conducted pre-post case-control study examining all included Cardio-STEMI Sanremo registry between February 2011 June 2013. Cases controls were defined according to P2Y12 inhibitors,...

10.1186/s12872-017-0524-3 article EN cc-by BMC Cardiovascular Disorders 2017-04-05

Abstract Background The PEGASUS-TIMI 54 trial inclusion criteria effectively identified high-risk patients with recent myocardial infarction (MI) who would benefit from continuing dual antiplatelet therapy (DAPT) ticagrelor for more than 12 months. It is unknown how many real-world meet these during the acute phase of ST-elevation MI (STEMI), or extent to which predict a patient's risk and prognosis. Study objectives were: (1) determine proportion 54-like (PG-l) in cohort hospitalized STEMI...

10.1186/s12872-020-01780-y article EN cc-by BMC Cardiovascular Disorders 2021-03-18

Aortic Stenosis (AS) has become the most frequent valvular heart disease in western countries with increased prevalence elderly. It is associated very poor prognosis absence of surgical treatment and worse quality life. Patients aged between 80 - 85 years no major comorbidities left ventricular ejection fraction 30% 50% are still not referred to valve surgery, even if these subjects would likely benefit from surgery terms duration life as compared expected outcome disease. The decision...

10.4236/wjcs.2012.24019 article EN cc-by World Journal of Cardiovascular Surgery 2012-01-01

The recent outbreak exposed doctors to a new challenge: treating people without any scientific evidence. All molecules combined in treatment schedules were merged on the basis of weak and anecdotal data so, recommendations are constantly changing. In this context it is either mandatory for clinicians focusing different options probable side effects each molecules. It well acquired that among elderly within same age group strain, outcome will differ according patient’s frailty. Moreover, old...

10.4081/gc.2020.9128 article EN cc-by-nc Geriatric Care 2020-08-27

Abstract Background The negative prognostic effect of chronic kidney disease (CKD), anaemia and diabetes in patients with acute coronary syndromes is well known. However, data about the prevalence importance these comorbidities unselected, contemporary STEMI treated primary PCI are limited. Purpose We sought to investigate CKD, mellitus this patient population, as possible interactions between comorbidities. Methods Between January 2006 December 2018, 3395 consecutive underwent two centres....

10.1093/ehjci/ehaa946.1775 article EN European Heart Journal 2020-11-01

Latest on STEMIResults: Mean age 61±11.9years, 77.6% men.The mean prevalence of transfer STEMI pts for reperfusion was 37% (95% CI,.Primary angioplasty and overall were inferior in vs non-transfer pts: 80% 86% (OR 0.65, 95% CI 0.50-0.84;p<0.001) 71% 83% 0.51; 0.39-0.67;p<0.001) respectively.The use thrombolysis higher 29% 17% (OR: 1.92, 1.48-2.50;p<0.001) respectively.Rescue performed 41 transferred 12 non-transferred pts; pharmacoinvasive strategy only used (6 transferred).Total ischemic...

10.1093/eurheartj/ehx493.p5591 article EN European Heart Journal 2017-08-01

Coronary artery disease -Epidemiology and outcomes 1 / 2 543 lyzed groups.At 36-month patients with 1-st degree obesity had the lowest, while underweight 3-rd were associated highest rates of mortality (26.7% for underweight, 12.1% normal weight, 10.8% overweight, 8.0% obesity, 10.1% 2-nd 17.2% 3rd obesity; P=0.0006).Incidence MI ACS-driven revascularization comparable in analyzed groups.In Cox proportional hazards model, was an independent factor favorable 3-year (hazard ratio 0.71; 95%...

10.1093/eurheartj/ehy565.p2685 article EN European Heart Journal 2018-08-01

Abstract Background Contrast–induced acute kidney injury (CI–AKI) is a percutaneous coronary intervention’s (PCI) feared complication, linked to increased morbidity and mortality. Many risk factors have been identified. Amongst procedural variables contrast media (CM) volume one of the most predictive. An easy–to–use effective CM sparing device would represent valuable tool in cath–lab armamentarium. Aim To evaluate effectiveness DyeVert Power XT system reducing delivery during PCI pts at...

10.1093/eurheartj/suac012.073 article EN European Heart Journal Supplements 2022-05-01

scholarly articles on cardiology Journal of Cardiology & Cardiovascular Therapy is an Open Access, international peer reviewed journal launched from Juniper Publishers. a branch medicine deals with the disorders heart that keeps cardiologists up to date advances in diagnosis and treatment cardiovascular diseases.

10.19080/jocct.2021.16.555950 article EN Journal of Cardiology & Cardiovascular Therapy 2021-04-20
Coming Soon ...